| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
7e-05 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0002 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0003 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0007 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.0009 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |